Additional Efficacy Data Showsthursday News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Additional Efficacy Data Showsthursday. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Additional Efficacy Data Showsthursday Today - Breaking & Trending Today

lupus nephritis

Published: April 8, 2021

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)'s Voclosporin is about to begin Phase 3 trials for first-line treatment of lupus nephritis. The company could be an “ideal acquisition candidate once Phase 3 kicks off,” Mackie Research Capital’s André Uddin said in a report. Uddin... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

Source: benzinga.com

Related Topics:

Aspreva PharmacueticalsElemer PirosAurinia Pharmaceuticals IncNational Kidney FoundationCantor FitzgeraldHealth CareMackie Research Capital AndrDuring The National Kidney FoundationAdditional Efficacy Data ShowsthursdayPharmaceuticals IncData Lifts StockSuggests Big PotentialfridayRemains ParamountwednesdayResearch Capitalஒரினிய மருந்துகள் இன்க்தேசிய கிட்நீ அடித்தளம்கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட்ஆரோக்கியம் பராமரிப்புபோது தி தேசிய கிட்நீ அடித்தளம்மருந்துகள் இன்க்ஆராய்ச்சி மூலதனம்